POEMS syndrome (Q94853): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 10:23, 16 August 2026
POEMS syndrome is defined by the presence of a peripheral neuropathy (P), a monoclonal plasma cell disorder (M), and other paraneoplastic features, the most common of which are organomegaly (O), endocrinopathy (E), skin changes (S), papilledema, edema, effusions, ascites, and thrombocytosis. Virtually all patients will have either at least one sclerotic bone lesion or concomitant Castleman disease. Associated neural autoantibodies are: Immunoglobulin G or Immunoglobulin A with lambda light chain, increased Vascular Endothelial Growth Factor (VEGF).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1555299114 |
||
| English | POEMS syndrome |
POEMS syndrome is defined by the presence of a peripheral neuropathy (P), a monoclonal plasma cell disorder (M), and other paraneoplastic features, the most common of which are organomegaly (O), endocrinopathy (E), skin changes (S), papilledema, edema, effusions, ascites, and thrombocytosis. Virtually all patients will have either at least one sclerotic bone lesion or concomitant Castleman disease. Associated neural autoantibodies are: Immunoglobulin G or Immunoglobulin A with lambda light chain, increased Vascular Endothelial Growth Factor (VEGF). |
Statements
CID11:ID_1555299114
0 references
dki-india-ID_1555299114
0 references
Concluído
0 references
15 August 2026
0 references
